Eva M. Schmelz

The effects of cancer progression on the viscoelasticity of ovarian cell cytoskeleton structures

Alperen N. Ketene, Eva M. Schmelz, Paul Roberts et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 218 citations

Mechanobiology, Engineering, Biomechanics +13

Colonic Cell Proliferation and Aberrant Crypt Foci Formation Are Inhibited by Dairy Glycosphingolipids in 1,2-Dimethylhydrazine-Treated CF1 Mice

Eva M. Schmelz, M. Cameron Sullards, Dirck L. Dillehay et al. · Journal of Nutrition · 2000 · 208 citations · Full text

Inflammation, Mucosal Immunology, Cell Signaling +9

Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis.

Eva M. Schmelz, Dirck L. Dillehay, Sonji K Webb et al. · PubMed · 1996 · 194 citations

Colon Carcinogenesis, Chemoprevention Strategy, Medicine +12

Induction of Apoptosis by Fumonisin B1in HT29 Cells Is Mediated by the Accumulation of Endogenous Free Sphingoid Bases

Eva M. Schmelz, Mary Ann Dombrink-Kurtzman, Paul C. Roberts et al. · Toxicology and Applied Pharmacology · 1998 · 157 citations

Apoptosis, Immunology, Cell Death +4

Selective concentration of human cancer cells using contactless dielectrophoresis

Erin A. Henslee, Michael B. Sano, Andrea D. Rojas et al. · Electrophoresis · 2011 · 127 citations